Share this post on:

Product Name: 6α-hydroxy Paclitaxel
Synonyms: βS-(benzoylamino)-αR-hydroxy-(2aR,3S,4R,4aS,6R,9S,11S,12S,12aR,12bS,)-6,12b-bis(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-3,4,11-trihydroxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca[3,4]benz[1,2-b]oxet-9-yl esterWeb Site:Medchemexpress
Product Overview: A primary metabolite of the anti-cancer compound paclitaxel, produced by the action of the CYP450 isoform CYP2C86α-hydroxy Paclitaxel is a primary metabolite of the anticancer compound paclitaxel (Item No. 10461), produced by the action of the cytoc
Shipping: wet ice
CAS NO: 5959-95-5 Product: D-Glutamine
Stability: Store at -20 degrees; shelf life 730 days maximum after production
Molecular Formula: C47H51NO15
SMILES: O[C@@H](C(O[C@H]1C[C@]([C@H]2OC(C3=CC=CC=C3)=O)(O)C(C)(C)C([C@@H](OC(C)=O)C([C@@]4(C)[C@@]2([H])[C@](OC(C)=O)(CO5)[C@H]5[C@@H](O)[C@@H]4O)=O)=C1C)=O)[C@@H](NC(C6=CC=CC=C6)=O)C7=CC=CC=C7P2Y Receptor inhibitors
Molecular Weight: 869.9
Formulation: A crystalline solid
Purity: ≥95%PubMed ID:http://aac.asm.org/content/55/3/1287.abstract

Share this post on:

Author: signsin1dayinc

Share this post on:

Product Name: 6α-hydroxy Paclitaxel
Synonyms: βS-(benzoylamino)-αR-hydroxy-(2aR,3S,4R,4aS,6R,9S,11S,12S,12aR,12bS,)-6,12b-bis(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-3,4,11-trihydroxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca[3,4]benz[1,2-b]oxet-9-yl esterWeb Site:Medchemexpress
Product Overview: A primary metabolite of the anti-cancer compound paclitaxel, produced by the action of the CYP450 isoform CYP2C86α-hydroxy Paclitaxel is a primary metabolite of the anticancer compound paclitaxel (Item No. 10461), produced by the action of the cytoc
Shipping: wet ice
CAS NO: 5959-95-5 Product: D-Glutamine
Stability: Store at -20 degrees; shelf life 730 days maximum after production
Molecular Formula: C47H51NO15
SMILES: O[C@@H](C(O[C@H]1C[C@]([C@H]2OC(C3=CC=CC=C3)=O)(O)C(C)(C)C([C@@H](OC(C)=O)C([C@@]4(C)[C@@]2([H])[C@](OC(C)=O)(CO5)[C@H]5[C@@H](O)[C@@H]4O)=O)=C1C)=O)[C@@H](NC(C6=CC=CC=C6)=O)C7=CC=CC=C7P2Y Receptor inhibitors
Molecular Weight: 869.9
Formulation: A crystalline solid
Purity: ≥95%PubMed ID:http://aac.asm.org/content/55/3/1287.abstract

Share this post on:

Author: signsin1dayinc